Transfusion-related acute lung injury (TRALI)
Overview
TRALI is a non-cardiogenic acute lung injury occurring within 6 hours of blood transfusion - one of the leading causes of transfusion-related mortality in the UK. Distinguishing it from TACO is the key clinical and exam challenge.
Pathophysiology
•Donor plasma antibodies (anti-HLA class I/II or anti-HNA) react with recipient leucocytes - massive neutrophil activation in pulmonary capillaries
•Increased pulmonary capillary permeability → protein-rich alveolar flooding (non-cardiogenic; left atrial pressure is normal)
•'Two-hit' model: first hit = pre-existing inflammation (sepsis, surgery, haematological malignancy) primes neutrophils; second hit = transfusion activates them
•Most commonly associated with plasma-rich products - FFP and apheresis platelets carry the highest antibody load
Presentation
•Onset within 6 hours of transfusion (usually during or shortly after)
•Acute breathlessness, non-productive cough, hypoxia (SpO2 drop), tachypnoea, tachycardia
•Hypotension - key distinguishing feature from TACO
•Fever and rigors - due to inflammatory response
•No peripheral oedema, no raised JVP, no hypertension
Investigations
•CXR - bilateral pulmonary infiltrates; normal heart size (helps differentiate from TACO)
•ABG - confirms hypoxaemia; PaO2:FiO2 <300 mmHg
•BNP/NT-proBNP - normal or minimally elevated in TRALI; significantly elevated in TACO - key discriminatory test
•FBC - may show transient leucopenia (neutrophil margination in lungs)
•Anti-leucocyte antibody testing (HLA class I/II and HNA) - donor and recipient samples; retrospective confirmation
•Echocardiography - normal LV function and filling pressures in TRALI; useful when BNP equivocal
Diagnostic criteria
•Acute onset of new/worsening respiratory symptoms
•Bilateral pulmonary infiltrates on CXR
•Hypoxaemia - SpO2 <90% on room air, or PaO2:FiO2 ratio <300 mmHg
•No evidence of pre-existing acute lung injury before transfusion
•No evidence of circulatory overload (TACO) as the primary cause
•Onset within 6 hours of completing blood component transfusion
Management
🥇 First-line
•stop the transfusion immediately - keep IV line open with normal saline
•high-flow supplemental oxygen via non-rebreather mask; titrate to SpO2 >94%
🥈 Second-line
•non-invasive ventilation (CPAP or BiPAP) if hypoxaemia not corrected with high-flow oxygen
🥉 Third-line
•invasive mechanical ventilation using lung-protective strategy (low tidal volume, as in ARDS)
•Send implicated blood unit and post-transfusion patient sample to blood bank for anti-leucocyte antibody testing
•Report via SHOT and to MHRA (Yellow Card scheme) as a serious adverse reaction
Prevention
•Male-only plasma donation (UK NHSBT policy) - multiparous women develop HLA antibodies through pregnancy; male donors have very low HLA antibody prevalence
•Leucodepletion of all blood components - standard UK practice since 1999
•HLA antibody screening of female donors who have been pregnant - deferred from plasma donation if antibodies detected
Prognosis
•Most patients improve with supportive care within 48-96 hours; generally better prognosis than ARDS from other causes
•Implicated donor must be deferred pending investigation; permanently deferred if antibodies confirmed reactive against recipient antigens
TRALI vs TACO
TRALI vs TACO - key differentiators
| Feature | TRALI | TACO |
|---|---|---|
| Mechanism | Non-cardiogenic (capillary leak) | Cardiogenic (fluid overload) |
| Blood pressure | Hypotension | Hypertension |
| JVP / peripheral oedema | Absent | Raised JVP, oedema |
| BNP/NT-proBNP | Normal / minimally elevated | Significantly elevated |
| CXR | Bilateral infiltrates, normal heart size | Bilateral infiltrates, cardiomegaly |
| Fluid balance | Not positive | Positive |
| Diuretics | Contraindicated - worsens hypotension | First-line treatment |